Bone Biologics Corp (BBLG)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Key ratios (FY2025)
-57.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $1.07B | $1.07B | — | — | — |
| Operating Income | -$3.23M | -$4.22M | -$9.43M | -$3.67M | -$1.10M | -$825.0K | -$2.45M | -$2.79M | -$2.63M | -$20.41M |
| Net Income | -$3.11M | -$4.11M | -$8.95M | -$1.48M | -$1.61M | -$1.82M | -$3.42M | -$4.43M | -$7.05M | -$25.88M |
| EPS (Diluted) | $-2.65 | $-28.96 | $-34.01 | $-31.15 | $-0.35 | — | — | — | — | — |
| Total Assets | $5.80M | $3.86M | $3.74M | $8.50M | $6.68M | $0 | $30.8K | $1.04M | $795.7K | $701.1K |
| Total Liabilities | $418.6K | $377.7K | $831.4K | $2.55M | $99.9K | $13.69M | $11.90M | $9.64M | $9.19M | $9.06M |
| Shareholders' Equity | $5.38M | $3.48M | $2.91M | $5.95M | $6.58M | -$13.69M | -$11.87M | -$8.60M | -$8.40M | -$8.36M |
| Cash & Equivalents | — | — | — | — | $6.68M | — | $24.1K | $955.4K | $690.3K | $620.4K |
| Operating Cash Flow | -$2.69M | -$4.12M | -$9.56M | -$3.57M | -$1.23M | -$426.9K | -$3.25M | -$4.10M | -$3.33M | -$7.33M |
| Shares Outstanding | 1.80M | 492.4K | 534.2K | 63.8K | 10.35M | 12.27M | 30.68M | 26.45M | 4.33M | 38.83M |